BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 6145677)

  • 1. Comparative study with oxmetidine and ranitidine on acid secretion and gastrin release in the dog.
    Soldani G; Del Tacca M; Polloni A; Bernardini C; Martinotti E
    Int J Tissue React; 1984; 6(2):181-4. PubMed ID: 6145677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
    Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisecretory and antiulcer activities of a potent new histamine H2-receptor antagonist with an intermediate duration of action.
    Borella L; Russell J; Rimele TJ; Grimes D; Failli A; Mir GN
    Arzneimittelforschung; 1988 Mar; 38(3):366-72. PubMed ID: 2898247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ORF 17583, other histamine H2-receptor antagonists and omeprazole on gastric acid secretory states in rats and dogs.
    Katz LB; Tobia AJ; Shriver DA
    J Pharmacol Exp Ther; 1987 Aug; 242(2):437-42. PubMed ID: 2886642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
    Cavanagh RL; Usakewicz JJ; Buyniski JP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effects of ranitidine, famotidine and omeprazole on plasma gastrin in the rat.
    Decktor DL; Pendleton RG; Kellner AT; Davis MA
    J Pharmacol Exp Ther; 1989 Apr; 249(1):1-5. PubMed ID: 2565384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic administration of H2-antagonists does not alter gastric secretory responses to histamine, or the antisecretory activity of sufotidine.
    Stables R; Humphray JM; Reeves JJ
    Aliment Pharmacol Ther; 1990; 4 Suppl 1():7-13. PubMed ID: 1983348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antisecretory profile of action of the H2-receptor antagonists, famotidine, loxtidine, ranitidine and L-643,441 on the rat isolated gastric mucosa.
    Reeves JJ; Stables R
    Agents Actions; 1987 Feb; 20(1-2):22-8. PubMed ID: 2883848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the H2 receptor antagonist and gastric acid antisecretory properties of Wy-45,727.
    Nielsen ST
    J Pharmacol Exp Ther; 1987 Aug; 242(2):607-13. PubMed ID: 2886646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of pirenzepine on gastric acid secretion and gastrin release induced by bombesin and meal in the dog.
    Del Tacca M; Soldani G; Polloni A; Bernardini C; Martinotti E
    Scand J Gastroenterol Suppl; 1982; 72():105-10. PubMed ID: 6957977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of ORF 17578, a new histamine H2-receptor antagonist: comparison with cimetidine and ranitidine.
    Katz LB; Scott CK; Shriver DA
    J Pharmacol Exp Ther; 1986 May; 237(2):404-10. PubMed ID: 2871172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the 2-deoxy-D-glucose-induced vagal stimulation of gastric secretion and gastrin release in dogs using methionine-enkephalin, morphine and naloxone.
    Anderson W; Molina E; Rentz J; Hirschowitz BI
    J Pharmacol Exp Ther; 1982 Sep; 222(3):617-22. PubMed ID: 6809930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of three single doses of oxmetidine administered intravenously on the volume and acidity of gastric secretion, serum prolactin and gastrin concentration in healthy volunteers.
    Wichmann GC; Fölsch UR; von Kleist E; Hasse FM; Dillon M; Clowdus B; Creutzfeldt W
    Z Gastroenterol; 1984 Jun; 22(6):285-93. PubMed ID: 6147051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the new H2-receptor antagonist mifentidine on gastric acid secretion in the cat: comparison with cimetidine and ranitidine.
    Scarpignato C; Tramacere R; Tangwa M; Bertaccini G
    Arch Int Pharmacodyn Ther; 1985 Jul; 276(1):142-51. PubMed ID: 2864903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological comparison of ORF 17910, a potent, long-acting histamine H2-receptor antagonist, to cimetidine and ranitidine.
    Katz LB; Scott CK; Shriver DA
    J Pharmacol Exp Ther; 1986 Aug; 238(2):587-93. PubMed ID: 2874214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of four H2 histamine antagonists on bethanechol-stimulated acid and pepsin secretion in the dog.
    Hirschowitz BI; Molina E
    J Pharmacol Exp Ther; 1983 Feb; 224(2):341-5. PubMed ID: 6130143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the animal pharmacology of ranitidine--a new, selective histamine H2-antagonist.
    Brittain RT; Daly MJ
    Scand J Gastroenterol Suppl; 1981 Jun; 69():1-9. PubMed ID: 6119770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of secretagogue selection on potency determinations for gastric acid antisecretory agents.
    Palumbo GJ; Nielsen ST
    Methods Find Exp Clin Pharmacol; 1988 Mar; 10(3):151-5. PubMed ID: 2898575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of mifentidine, a novel H2-receptor antagonist.
    Pagani F; Micheletti R; Brambilla A; Schiavone A; Montagna E; Ciprandi C; Giachetti A
    Arzneimittelforschung; 1985; 35(1A):451-5. PubMed ID: 2859036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gastric acid secretion and histamine H2 receptor antagonists].
    Gespach C; Emami S; Di Gioia Y; Chastre E
    Gastroenterol Clin Biol; 1990; 14(12):982-94. PubMed ID: 1981198
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.